Neville F. Ford - Concepedia

Author

Neville F. Ford

Bristol-Myers Squibb (United States)

Also Known As

N F Ford, N FORD, N. F. FORD, N. F. Ford, N. Ford, N.F. Ford, Neville F Ford, Neville F. Ford, Neville Ford

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Clinical Research Associates Virginia Commonwealth University Medical Center Princeton University

About

Neville F. Ford is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	260
2	Engineering	1	1	58
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	18
5	Biochemistry	1	1	18

Neville F. Ford

Publications

746

Citations

H-Index

Page 1

	Year	Citations
Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors Neville F. Ford, Leslie J. Browne, Thomas Campbell, Journal of Medicinal Chemistry	1985	106
Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency Domenic A. Sica, Ralph E. Cutler, Robert J. Parmer, Clinical Pharmacokinetics UrologyRenal FunctionMedicineKidney FailureChronic Kidney Disease	1991	80
The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents Abdullah Şakarcan, Frank Tenney, John T. Wilson, The Journal of Clinical Pharmacology	2001	80
Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects Maria Rosaria Marino, Kathleen M. Langenbacher, Neville F. Ford, The Journal of Clinical Pharmacology	1998	70
Measurement of 2,4-Toluenediamine in Urine and Serum Samples from Women with Même or Replicon Breast Implants Roderick T. Hester, Neville F. Ford, Jane P. Gale, Plastic & Reconstructive Surgery UrologyPolyurethane FoamPolyurethane Foam CoverEngineeringMedicine	1997	58
The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis* Domenic A. Sica, Maria Rosaria Marino, J HAMMETT, Clinical Pharmacology & Therapeutics	1997	56
Pharmacokinetics and Pharmacodynamics of Irbesartan in Patients with Hepatic Cirrhosis Maria R. Marino, Kathleen M. Langenbacher, Ralph Raymond, The Journal of Clinical Pharmacology	1998	47
Monitoring of Acute Migraine Attacks: Placebo Response and Safety Data Stanford S. Jhee, Daniel E. Salazar, Neville F. Ford, Headache The Journal of Head and Face Pain	1998	37
Defining the Maximum Tolerated Dose: Investigator, Academic, Industry and Regulatory Perspectives Neal R. Cutler, John J. Sramek, David J. Greenblatt, The Journal of Clinical Pharmacology Drug SafetyTherapeutic Drug MonitoringMedicineRegulatory PerspectivesPatient Safety	1997	33
Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography. Bradley Christian, Eli Livni, John W. Babich, Journal of Pharmacology and Experimental Therapeutics	1996	29

Page 1